NCT03078205

Brief Summary

Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan. Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 13, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

February 17, 2020

Status Verified

February 1, 2020

Enrollment Period

1.7 years

First QC Date

March 8, 2017

Last Update Submit

February 13, 2020

Conditions

Keywords

TCM multi-channel therapyART failure

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with successful conception

    10 weeks after embryo transplantation

Secondary Outcomes (2)

  • Time to have successful conception

    up to 26 weeks

  • Adverse events

    0, 10, 26 weeks after randomization

Study Arms (3)

The control group

NO INTERVENTION

No Intervention

The dual therapy group

EXPERIMENTAL

TCM prescriptionⅡof cultivated emotion and assisted reproduction +auricular acupoint therapy.

Other: The dual therapy

The triple therapy group

EXPERIMENTAL

TCM prescriptionⅡof cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM.

Other: The triple therapy

Interventions

TCM prescriptionⅡof cultivated emotion and assisted reproduction +auricular acupoint therapy

The dual therapy group

TCM prescriptionⅡof cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM

The triple therapy group

Eligibility Criteria

Age20 Years - 42 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • People aged 20 to 42
  • People with IVF - ET indications
  • People from Reproductive Center of West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) with long plan for IVE - ET Failure and then accept the secondary IVF-ET
  • People who conform to the standard of syndrome differentiation in TCM: kidney deficiency and liver depression and blood stasis
  • People with normal basic sex hormone levels
  • People who have recognized and voluntarily signed the informed consent. NOTICE: People who conform to the above 6 items can be included.

You may not qualify if:

  • The husband with less sperm and weak sperm seriously
  • People who have drug allergy or allergic constitution
  • People with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, etc. And mentally disordered patients
  • People who are complicated by acute infectious diseases and organic diseases
  • People have confirmed diagnosis malformed reproductive organs, reproductive system inflammation and tumors upon examination
  • People suffer from hereditary disease which is not suitable for fertility regulated in "maternal and infant health care law"
  • People who have the serious bad habits such as drug use
  • People who have contacted with birth defects rays, poison, drugs to a certain number and being in effect; NOTICE: People who conform to any of the terms above 9 will be ruled out.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China second University Hospital of Sichuan University

Chengdu, Sichuan, 610041, China

Location

Related Publications (1)

  • Zhou H, Zheng X, Xia W, Ma Q, Li J, Zeng Q, Huang J. The Efficacy and Safety of the Zhuyun Formula and Auricular Acupressure for the Infertile Women with Recurrent Implantation Failure: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2022 Oct 11;2022:5274638. doi: 10.1155/2022/5274638. eCollection 2022.

Study Officials

  • Qian Zeng

    Chengdu University of Traditional Chinese Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

March 8, 2017

First Posted

March 13, 2017

Study Start

May 1, 2016

Primary Completion

January 1, 2018

Study Completion

April 1, 2018

Last Updated

February 17, 2020

Record last verified: 2020-02

Locations